Contract Research and Manufacturing Service (CRAMS) Market in India 2024-2028

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Service
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning

2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics

3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 13: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 14: Chart on India: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on India: Year-over-year growth 2023-2028 (%)

4.1 Contract research and manufacturing service (CRAMS) market in India 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on contract research and manufacturing service (crams) market in India 2018 - 2022 ($ billion)
4.2 Service Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - Service Segment 2018 - 2022 ($ billion)
4.3 Therapeutic area Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - Therapeutic area Segment 2018 - 2022 ($ billion)
4.4 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)

5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

6.1 Market segments
Exhibit 27: Chart on Service - Market share 2023-2028 (%)
Exhibit 28: Data Table on Service - Market share 2023-2028 (%)
6.2 Comparison by Service
Exhibit 29: Chart on Comparison by Service
Exhibit 30: Data Table on Comparison by Service
6.3 Manufacturing - Market size and forecast 2023-2028
Exhibit 31: Chart on Manufacturing - Market size and forecast 2023-2028 ($ billion)
Exhibit 32: Data Table on Manufacturing - Market size and forecast 2023-2028 ($ billion)
Exhibit 33: Chart on Manufacturing - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on Manufacturing - Year-over-year growth 2023-2028 (%)
6.4 Research - Market size and forecast 2023-2028
Exhibit 35: Chart on Research - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Data Table on Research - Market size and forecast 2023-2028 ($ billion)
Exhibit 37: Chart on Research - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Research - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Service
Exhibit 39: Market opportunity by Service ($ billion)
Exhibit 40: Data Table on Market opportunity by Service ($ billion)

7.1 Market segments
Exhibit 41: Chart on Therapeutic Area - Market share 2023-2028 (%)
Exhibit 42: Data Table on Therapeutic Area - Market share 2023-2028 (%)
7.2 Comparison by Therapeutic Area
Exhibit 43: Chart on Comparison by Therapeutic Area
Exhibit 44: Data Table on Comparison by Therapeutic Area
7.3 Cardiovascular - Market size and forecast 2023-2028
Exhibit 45: Chart on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
Exhibit 46: Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Chart on Cardiovascular - Year-over-year growth 2023-2028 (%)
Exhibit 48: Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%)
7.4 Infectious disease - Market size and forecast 2023-2028
Exhibit 49: Chart on Infectious disease - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ billion)
Exhibit 51: Chart on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%)
7.5 Endocrine disease - Market size and forecast 2023-2028
Exhibit 53: Chart on Endocrine disease - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Data Table on Endocrine disease - Market size and forecast 2023-2028 ($ billion)
Exhibit 55: Chart on Endocrine disease - Year-over-year growth 2023-2028 (%)
Exhibit 56: Data Table on Endocrine disease - Year-over-year growth 2023-2028 (%)
7.6 Oncology - Market size and forecast 2023-2028
Exhibit 57: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibit 59: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibit 60: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.7 Gastrointestinal and others - Market size and forecast 2023-2028
Exhibit 61: Chart on Gastrointestinal and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Data Table on Gastrointestinal and others - Market size and forecast 2023-2028 ($ billion)
Exhibit 63: Chart on Gastrointestinal and others - Year-over-year growth 2023-2028 (%)
Exhibit 64: Data Table on Gastrointestinal and others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Therapeutic Area
Exhibit 65: Market opportunity by Therapeutic Area ($ billion)
Exhibit 66: Data Table on Market opportunity by Therapeutic Area ($ billion)

8.1 Market segments
Exhibit 67: Chart on End-user - Market share 2023-2028 (%)
Exhibit 68: Data Table on End-user - Market share 2023-2028 (%)
8.2 Comparison by End-user
Exhibit 69: Chart on Comparison by End-user
Exhibit 70: Data Table on Comparison by End-user
8.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
Exhibit 71: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
8.4 Medical device companies - Market size and forecast 2023-2028
Exhibit 75: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
8.5 Academic and research institutes - Market size and forecast 2023-2028
Exhibit 79: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
8.6 Market opportunity by End-user
Exhibit 83: Market opportunity by End-user ($ billion)
Exhibit 84: Data Table on Market opportunity by End-user ($ billion)

9.1 Customer landscape overview
Exhibit 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 86: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11.1 Overview
11.2 Vendor landscape
Exhibit 87: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 88: Overview on factors of disruption
11.4 Industry risks
Exhibit 89: Impact of key risks on business

12.1 Vendors covered
Exhibit 90: Vendors covered
12.2 Market positioning of vendors
Exhibit 91: Matrix on vendor position and classification
12.3 Aragen Life Sciences Pvt. Ltd.
Exhibit 92: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibit 93: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibit 94: Aragen Life Sciences Pvt. Ltd. - Key offerings
12.4 Aurobindo Pharma Ltd.
Exhibit 95: Aurobindo Pharma Ltd. - Overview
Exhibit 96: Aurobindo Pharma Ltd. - Product / Service
Exhibit 97: Aurobindo Pharma Ltd. - Key offerings
12.5 Biocon Ltd.
Exhibit 98: Biocon Ltd. - Overview
Exhibit 99: Biocon Ltd. - Business segments
Exhibit 100: Biocon Ltd. - Key news
Exhibit 101: Biocon Ltd. - Key offerings
Exhibit 102: Biocon Ltd. - Segment focus
12.6 Dhanuka Agritech Ltd.
Exhibit 103: Dhanuka Agritech Ltd. - Overview
Exhibit 104: Dhanuka Agritech Ltd. - Business segments
Exhibit 105: Dhanuka Agritech Ltd. - Key offerings
Exhibit 106: Dhanuka Agritech Ltd. - Segment focus
12.7 Dishman Carbogen Amcis Ltd.
Exhibit 107: Dishman Carbogen Amcis Ltd. - Overview
Exhibit 108: Dishman Carbogen Amcis Ltd. - Business segments
Exhibit 109: Dishman Carbogen Amcis Ltd. - Key offerings
Exhibit 110: Dishman Carbogen Amcis Ltd. - Segment focus
12.8 Divis Laboratories Ltd.
Exhibit 111: Divis Laboratories Ltd. - Overview
Exhibit 112: Divis Laboratories Ltd. - Product / Service
Exhibit 113: Divis Laboratories Ltd. - Key offerings
12.9 Ipca Laboratories Ltd.
Exhibit 114: Ipca Laboratories Ltd. - Overview
Exhibit 115: Ipca Laboratories Ltd. - Product / Service
Exhibit 116: Ipca Laboratories Ltd. - Key offerings
12.10 Jubilant Pharmova Ltd.
Exhibit 117: Jubilant Pharmova Ltd. - Overview
Exhibit 118: Jubilant Pharmova Ltd. - Business segments
Exhibit 119: Jubilant Pharmova Ltd. - Key offerings
Exhibit 120: Jubilant Pharmova Ltd. - Segment focus
12.11 Lupin Ltd.
Exhibit 121: Lupin Ltd. - Overview
Exhibit 122: Lupin Ltd. - Product / Service
Exhibit 123: Lupin Ltd. - Key news
Exhibit 124: Lupin Ltd. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 125: Merck and Co. Inc. - Overview
Exhibit 126: Merck and Co. Inc. - Business segments
Exhibit 127: Merck and Co. Inc. - Key news
Exhibit 128: Merck and Co. Inc. - Key offerings
Exhibit 129: Merck and Co. Inc. - Segment focus
12.13 MSN Laboratories
Exhibit 130: MSN Laboratories - Overview
Exhibit 131: MSN Laboratories - Product / Service
Exhibit 132: MSN Laboratories - Key offerings
12.14 Piramal Enterprises Ltd.
Exhibit 133: Piramal Enterprises Ltd. - Overview
Exhibit 134: Piramal Enterprises Ltd. - Product / Service
Exhibit 135: Piramal Enterprises Ltd. - Key offerings
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 136: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 137: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 138: Sun Pharmaceutical Industries Ltd. - Key news
Exhibit 139: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 TCG Lifesciences Pvt. Ltd.
Exhibit 140: TCG Lifesciences Pvt. Ltd. - Overview
Exhibit 141: TCG Lifesciences Pvt. Ltd. - Product / Service
Exhibit 142: TCG Lifesciences Pvt. Ltd. - Key offerings
12.17 Wockhardt Ltd.
Exhibit 143: Wockhardt Ltd. - Overview
Exhibit 144: Wockhardt Ltd. - Product / Service
Exhibit 145: Wockhardt Ltd. - Key offerings

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 146: Inclusions checklist
Exhibit 147: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 148: Currency conversion rates for US$
13.4 Research methodology
Exhibit 149: Research methodology
Exhibit 150: Validation techniques employed for market sizing
Exhibit 151: Information sources
13.5 List of abbreviations
Exhibit 152: List of abbreviations

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Service
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits 13: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits 14: Chart on India: Year-over-year growth 2023-2028 (%)
Exhibits 15: Data Table on India: Year-over-year growth 2023-2028 (%)
Exhibits 16: Historic Market Size - Data Table on contract research and manufacturing service (crams) market in India 2018 - 2022 ($ billion)
Exhibits 17: Historic Market Size - Service Segment 2018 - 2022 ($ billion)
Exhibits 18: Historic Market Size - Therapeutic area Segment 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 20: Five forces analysis - Comparison between 2023 and 2028
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 26: Chart on Market condition - Five forces 2023 and 2028
Exhibits 27: Chart on Service - Market share 2023-2028 (%)
Exhibits 28: Data Table on Service - Market share 2023-2028 (%)
Exhibits 29: Chart on Comparison by Service
Exhibits 30: Data Table on Comparison by Service
Exhibits 31: Chart on Manufacturing - Market size and forecast 2023-2028 ($ billion)
Exhibits 32: Data Table on Manufacturing - Market size and forecast 2023-2028 ($ billion)
Exhibits 33: Chart on Manufacturing - Year-over-year growth 2023-2028 (%)
Exhibits 34: Data Table on Manufacturing - Year-over-year growth 2023-2028 (%)
Exhibits 35: Chart on Research - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Data Table on Research - Market size and forecast 2023-2028 ($ billion)
Exhibits 37: Chart on Research - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Research - Year-over-year growth 2023-2028 (%)
Exhibits 39: Market opportunity by Service ($ billion)
Exhibits 40: Data Table on Market opportunity by Service ($ billion)
Exhibits 41: Chart on Therapeutic Area - Market share 2023-2028 (%)
Exhibits 42: Data Table on Therapeutic Area - Market share 2023-2028 (%)
Exhibits 43: Chart on Comparison by Therapeutic Area
Exhibits 44: Data Table on Comparison by Therapeutic Area
Exhibits 45: Chart on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
Exhibits 46: Data Table on Cardiovascular - Market size and forecast 2023-2028 ($ billion)
Exhibits 47: Chart on Cardiovascular - Year-over-year growth 2023-2028 (%)
Exhibits 48: Data Table on Cardiovascular - Year-over-year growth 2023-2028 (%)
Exhibits 49: Chart on Infectious disease - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ billion)
Exhibits 51: Chart on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Endocrine disease - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Data Table on Endocrine disease - Market size and forecast 2023-2028 ($ billion)
Exhibits 55: Chart on Endocrine disease - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Endocrine disease - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Data Table on Oncology - Market size and forecast 2023-2028 ($ billion)
Exhibits 59: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Gastrointestinal and others - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Data Table on Gastrointestinal and others - Market size and forecast 2023-2028 ($ billion)
Exhibits 63: Chart on Gastrointestinal and others - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Gastrointestinal and others - Year-over-year growth 2023-2028 (%)
Exhibits 65: Market opportunity by Therapeutic Area ($ billion)
Exhibits 66: Data Table on Market opportunity by Therapeutic Area ($ billion)
Exhibits 67: Chart on End-user - Market share 2023-2028 (%)
Exhibits 68: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 69: Chart on Comparison by End-user
Exhibits 70: Data Table on Comparison by End-user
Exhibits 71: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
Exhibits 83: Market opportunity by End-user ($ billion)
Exhibits 84: Data Table on Market opportunity by End-user ($ billion)
Exhibits 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 86: Impact of drivers and challenges in 2023 and 2028
Exhibits 87: Overview on Criticality of inputs and Factors of differentiation
Exhibits 88: Overview on factors of disruption
Exhibits 89: Impact of key risks on business
Exhibits 90: Vendors covered
Exhibits 91: Matrix on vendor position and classification
Exhibits 92: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits 93: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits 94: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits 95: Aurobindo Pharma Ltd. - Overview
Exhibits 96: Aurobindo Pharma Ltd. - Product / Service
Exhibits 97: Aurobindo Pharma Ltd. - Key offerings
Exhibits 98: Biocon Ltd. - Overview
Exhibits 99: Biocon Ltd. - Business segments
Exhibits 100: Biocon Ltd. - Key news
Exhibits 101: Biocon Ltd. - Key offerings
Exhibits 102: Biocon Ltd. - Segment focus
Exhibits 103: Dhanuka Agritech Ltd. - Overview
Exhibits 104: Dhanuka Agritech Ltd. - Business segments
Exhibits 105: Dhanuka Agritech Ltd. - Key offerings
Exhibits 106: Dhanuka Agritech Ltd. - Segment focus
Exhibits 107: Dishman Carbogen Amcis Ltd. - Overview
Exhibits 108: Dishman Carbogen Amcis Ltd. - Business segments
Exhibits 109: Dishman Carbogen Amcis Ltd. - Key offerings
Exhibits 110: Dishman Carbogen Amcis Ltd. - Segment focus
Exhibits 111: Divis Laboratories Ltd. - Overview
Exhibits 112: Divis Laboratories Ltd. - Product / Service
Exhibits 113: Divis Laboratories Ltd. - Key offerings
Exhibits 114: Ipca Laboratories Ltd. - Overview
Exhibits 115: Ipca Laboratories Ltd. - Product / Service
Exhibits 116: Ipca Laboratories Ltd. - Key offerings
Exhibits 117: Jubilant Pharmova Ltd. - Overview
Exhibits 118: Jubilant Pharmova Ltd. - Business segments
Exhibits 119: Jubilant Pharmova Ltd. - Key offerings
Exhibits 120: Jubilant Pharmova Ltd. - Segment focus
Exhibits 121: Lupin Ltd. - Overview
Exhibits 122: Lupin Ltd. - Product / Service
Exhibits 123: Lupin Ltd. - Key news
Exhibits 124: Lupin Ltd. - Key offerings
Exhibits 125: Merck and Co. Inc. - Overview
Exhibits 126: Merck and Co. Inc. - Business segments
Exhibits 127: Merck and Co. Inc. - Key news
Exhibits 128: Merck and Co. Inc. - Key offerings
Exhibits 129: Merck and Co. Inc. - Segment focus
Exhibits 130: MSN Laboratories - Overview
Exhibits 131: MSN Laboratories - Product / Service
Exhibits 132: MSN Laboratories - Key offerings
Exhibits 133: Piramal Enterprises Ltd. - Overview
Exhibits 134: Piramal Enterprises Ltd. - Product / Service
Exhibits 135: Piramal Enterprises Ltd. - Key offerings
Exhibits 136: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 137: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 138: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 139: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 140: TCG Lifesciences Pvt. Ltd. - Overview
Exhibits 141: TCG Lifesciences Pvt. Ltd. - Product / Service
Exhibits 142: TCG Lifesciences Pvt. Ltd. - Key offerings
Exhibits 143: Wockhardt Ltd. - Overview
Exhibits 144: Wockhardt Ltd. - Product / Service
Exhibits 145: Wockhardt Ltd. - Key offerings
Exhibits 146: Inclusions checklist
Exhibits 147: Exclusions checklist
Exhibits 148: Currency conversion rates for US$
Exhibits 149: Research methodology
Exhibits 150: Validation techniques employed for market sizing
Exhibits 151: Information sources
Exhibits 152: List of abbreviations